Reverse circadian glucocorticoid treatment in prepubertal children with congenital adrenal hyperplasia

Ilja Dubinski1, Susanne Bechtold Dalla-Pozza1, Martin Bidlingmaier2

  • 1Division for Pediatric Endocrinology, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Munich, Germany.

Insights

Reverse circadian treatment (RCT) for congenital adrenal hyperplasia (CAH) in children did not lower morning 17-hydroxyprogesterone (s17-OHP) levels and showed no benefits over standard therapy. Long-term risks of RCT remain unknown.

Area of Science:

  • Pediatric Endocrinology
  • Endocrinology
  • Genetics

Background:

  • Congenital adrenal hyperplasia (CAH) is a group of genetic disorders affecting steroid synthesis.
  • Salt-wasting CAH requires glucocorticoid (GC) and mineralocorticoid hormone replacement therapy.
  • Standard GC therapy involves thrice-daily hydrocortisone, mimicking physiological rhythms.

Purpose of the Study:

  • To evaluate the efficacy of reverse circadian treatment (RCT) in prepubertal children with CAH.
  • To compare salivary 17-hydroxyprogesterone (s17-OHP) levels in children receiving RCT versus standard therapy.
  • To determine if RCT effectively lowers morning s17-OHP concentrations.

Main Methods:

  • Retrospective analysis of 23 pediatric CAH patients' records.
  • Focused on nine prepubertal children on RCT, comparing s17-OHP levels at different times of day.
  • Intra-individual comparison of s17-OHP profiles in six patients on RCT versus non-RCT therapy.

Main Results:

  • Eight of nine children on RCT had higher morning s17-OHP levels than evening levels.
  • No significant developmental deviations, adrenal crises, or pubertal development were observed.
  • No difference in 17-OHP profiles was found between RCT and non-RCT regimens.

Conclusions:

  • Current data do not support the use of RCT for GC replacement in pediatric CAH.
  • RCT demonstrated a lack of benefits in managing s17-OHP levels.
  • Unknown long-term risks associated with RCT warrant caution.
Abstract

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
2.2K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
240
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
463
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
169
Hormones of the Adrenal Glands01:31

Hormones of the Adrenal Glands

Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and...
3.2K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
456